
About
Viral Hemorrhagic Fevers (VHFs) are a group of diseases that are caused by several distinct families of viruses. They have been identified in many areas of the world including some parts of Africa, Asia, and South America. Anyone can get a viral hemorrhagic fever, but most people can be infected when living or visiting areas where there are infected rodents, bats or arthropods. VHFs can be spread through blood, stool or urine of infected animals, or insect bites. Certain VHFs (Ebola, Marburg, Lassa fever, Lujo, Crimean-Congo hemorrhagic fever, Junin, Machupo, Chapare, Guanarito, and Sabia viruses) can spread from person-to-person through direct contact with the bodily fluids (i.e., blood or secretions) of an infected person or exposure to objects (such as needles) that have been contaminated with infected bodily fluids. Family members living with or taking care of an infected person or healthcare workers taking care of an ill person with VHF are examples of those most at risk. VHFs can cause mild illness or more life-threatening disease. Symptoms can vary but may include bleeding or hemorrhaging. People cannot transmit the disease before they have symptoms and remain infectious as long as their blood contains the virus. VHFs are not respiratory diseases like the flu or COVID-19, and not transmitted through the air. Although hantavirus, dengue, and yellow fever are classified as VHFs, they are not covered here.
For evaluation or questions about possible cases, contact:
Acute Communicable Disease Control Program
Mon-Fri 8am-5pm:
213-240-7941
After Hours:
213-974-1234 (ask for physician on call, AOD)
News and Updates
- Tanzania confirms outbreak of Marburg virus disease (World Health Organization, 1-20-2025)
- Recommendations for organizations sending U.S.-based healthcare or emergency response personnel to areas with viral hemorrhagic fever (VHF) outbreaks (Centers for Disease Control and Prevention, 5-15-24)
Common Symptoms and Treatment
Symptoms
VHF symptoms can appear anywhere from 2 to 21 days after exposure to the virus. Illness typically progresses from "dry" symptoms (fever, aches, fatigue) to "wet" symptoms (diarrhea, vomiting, and in some cases, bleeding). A person with a VHF is not contagious until the appearance of symptoms. Primary signs and symptoms of VHFs often include some or several of the following:
- Fever (≥100.4°F/38.0°C)
- Aches and pains, such as severe headache and muscle and/or joint pain
- Weakness and fatigue
- Cough/difficulty breathing
- Sore throat
- Loss of appetite
- Gastrointestinal symptoms including abdominal pain, diarrhea, and vomiting
- Chest pain
- Encephalitis
- Acute hearing loss
- Unexplained hemorrhaging, bleeding or bruising
- Red eyes, skin rash, and hiccups
Treatment
- Healthcare providers should notify their health department and CDC to determine a patient's course of treatment.
- FDA-approved therapeutics do not exist for most viral hemorrhagic fevers.
- Supportive care is vital for patients with suspected or confirmed VHFs.
Transmission and Prevention
Transmission
VHFs can spread through contact with infected animals, infected insects or contact with the body or body fluids of an infected person depending on the type of VHF. In general VHF can spread by:
- Contact with Animals
- Handling infected animals, alive or dead.
- Being bitten by infected mosquitoes or ticks.
- Contact with urine, feces, or saliva from infected animals.
- Inhaling airborne particles from infected animal urine or feces.
- Human-Human
- Close contact with infected people or their body fluids.
- Sexual contact with an infected person.
- Touching objects contaminated with infected body fluids.
Prevention
- Avoid traveling to areas with active outbreaks.
- Before travel, check the CDC Travel Health Notices site for recommendations.
Travelers visiting risk areas should:
- Avoid physical contact with ill people and dead bodies.
- Avoid contact with sick or dead animals.
- Avoid contact with rodents, bats, primates and other animals that can carry VHFs.
- Avoid handling, cooking, or eating raw or undercooked bushmeat or animal products.
- Use insect repellents, bed nets, and protective clothing to avoid mosquito and tick bites.
Information for Clinicians and Healthcare Professionals
VHF Clinical Information and Management
Evaluating an ill person for VHF
- Guide for Clinicians Evaluating an Ill Person for VHF or Other High-Consequence Disease (CDC)
- Lab Testing
Infection Control for Known or Suspected Ebola
- Infection Prevention and Control Recommendations for Patients in U.S. Hospitals who are Suspected or Confirmed to have Selected Viral Hemorrhagic Fevers (CDC)
- Interim Guidance for Environmental Infection Control in Hospitals (CDC)
- Handling VHF-Associated Waste (CDC)
- Safe Handling of Human Remains of VHF Patients in U.S. Hospitals and Mortuaries (CDC)
- Ebola Virus Disease (CDPH)
- Disinfectants for Use Against Ebola Virus (EPA)
- Disinfectants for Use Against Marburg Virus (EPA)
Personal Protective Equipment (PPE)
- Interim Guidance on Personal Protective Equipment (PPE) in the Hospital Setting During Management of Suspected or Confirmed Ebola Patients (CDPH)
- Guidance for Personal Protective Equipment (PPE) (CDC)
- PPE: Confirmed Patients and Clinically Unstable Patients Suspected to have VHF (CDC)
- PPE: Clinically Stable Patients Suspected to have VHF (CDC)
- PPE FAQs (CDC)
Resources
- NETEC: National Emerging Special Pathogens Training and Education Center
- Ebola Virus Disease (CDPH)
- National Notifiable Diseases Viral Hemorrhagic Fever Case Definition (CDC)
LAC DPH Resources
- Viral Hemorrhagic Fever (VHF) Identify Isolate and Inform (10-7-24)
- LAC DPH Guidance for Organizations who send Healthcare Volunteers and Those Working in Areas with Viral Hemorrhagic Fever (VHF) Outbreaks (10-4-24)
- B73: Viral Hemorrhagic Fevers
- B73: Index Communicable Disease Control Manual
- LAC DPH General Health Education Materials
Ebola Special Studies Report 2015
- Monitoring West African Travelers for Ebola Virus Disease in Los Angeles County: A Complete Review
- Pregnancy, Labor, and Delivery After Ebola Virus Disease and Implications for Infection Control in Obstetric Services, US
- The Utility of a Mobile Ebola Assessment for Persons Under Investigation
- Toward an Individualized Approach to Define Fever Among Travelers from Ebola-Affected Countries or Persons with Exposure to an Ebola Patient